Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT04414202
Eligibility Criteria:
Inclusion Criteria:
* Women 60 years of age or older,
* Histologically proven invasive ductal breast cancer or of a histologically favorable sub-type (mucinous, tubular or colloid),
-. Unifocal tumor,
* T1 (diameter ≤ 20 mm),
* N0 (pN0 or pNi+),
* M0,
* Gland exeresis margins ≥ 2 mm,
* Estrogen receptor positive,
* Information and non-opposition of the patient.
Exclusion Criteria:
-. Inflammatory breast cancer,
* Associated peri-tumoral lymphatic emboli
* Associated extensive intra-ductal component
* Invasive lobular carcinoma
* Pure ductal carcinoma in situ,
* Sarcoma or lymphoma-type non-epithelial tumor
* Synchronous bilateral breast cancer,
* Any prior neo-adjuvant treatment: radiotherapy, chemotherapy, hormone therapy
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
60 Years
Study:
NCT04414202
Study Brief:
Protocol Section:
NCT04414202